Baudax Bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $1.16 | $1.98 | $1.57 |
| Q2 2024 | 0 | $0.99 | $1.69 | $1.34 |
| Q3 2024 | 0 | $1.14 | $1.94 | $1.54 |
Baudax Bio, Inc. Earnings Date And Information
Baudax Bio, Inc. last posted its earnings results on Monday, November 20th, 2023. The company reported $-0.29 earnings per share for the quarter, topping analysts' consensus estimates of $-0.53 by $0.24. The company had revenue of 0 for the quarter and had revenue of 1.27 M for the year. Baudax Bio, Inc. has generated $-177 earnings per share over the last year ($-177.3 diluted earnings per share) and currently has a price-to-earnings ratio of -0.16. Baudax Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 18th, 2024 based on prior year's report dates.
Baudax Bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/20/2023 | Q3 2023 | -$0.53 | -$0.24 | 0.29 | $524,535 | $0 |
| 08/16/2023 | Q2 2023 | -$2.04 | -$1.51 | 0.53 | $206,728 | $30,000 |
| 05/11/2023 | Q1 2023 | $4.91 | $-14,000 | |||
| 02/23/2023 | Q4 2022 | $9.76 | -$5.70 | -15.46 | $310,000 | |
| 11/08/2022 | Q3 2022 | -$21.20 | -$98.70 | -77.5 | $561,000 | $238,000 |
| 08/11/2022 | Q2 2022 | -$50.80 | -$41.95 | 8.85 | $187,935 | $300,000 |
| 05/05/2022 | Q1 2022 | -$79.89 | $422,000 | |||
| 03/16/2022 | Q4 2021 | $59.00 | $446.40 | 387.4 | $400,000 | |
| 11/04/2021 | Q3 2021 | -$223.78 | -$281.20 | -57.42 | $600,000 | $281,000 |
| 08/05/2021 | Q2 2021 | -$307.69 | -$286.80 | 20.89 | $201,000 | $201,000 |
| 05/05/2021 | Q1 2021 | -$265.73 | -$378.40 | -112.67 | $198,000 | |
| 02/16/2021 | Q4 2020 | -$849.33 | -$490.05 | 359.28 | $76,000 | |
| 11/09/2020 | Q3 2020 | -$1,174.83 | $896.01 | 2070.84 | $173,675 | $68,000 |
| 08/10/2020 | Q2 2020 | -$1,034.97 | -$2,408.04 | -1373.07 | $131,889 | $349,000 |
| 05/08/2020 | Q1 2020 | -$1,272.73 | -$5,642.08 | -4369.35 | $0 | |
| 02/13/2020 | Q4 2019 | -$1,311.33 | -$1,096.89 | 214.44 | $0 | |
| 11/14/2019 | Q3 2019 | -$1,590.84 | $0 | |||
| 06/29/2019 | Q2 2019 | -$1,632.02 | $0 | |||
| 03/30/2019 | Q1 2019 | -$668.57 | $0 | |||
| 12/30/2018 | Q4 2018 | -$2,572.64 | $0 |
Baudax Bio, Inc. Earnings: Frequently Asked Questions
-
When is Baudax Bio, Inc.'s earnings date?
Baudax Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 18th, 2024 based off last year's report dates.
-
Did Baudax Bio, Inc. beat their earnings estimates last quarter?
In the previous quarter, Baudax Bio, Inc. (:BXRX) reported $-0.29 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.53 by $0.24.
-
How can I listen to Baudax Bio, Inc.'s earnings conference call?
The conference call for Baudax Bio, Inc.'s latest earnings report can be listened to online.
-
How can I read Baudax Bio, Inc.'s conference call transcript?
The conference call transcript for Baudax Bio, Inc.'s latest earnings report can be read online.
-
How much revenue does Baudax Bio, Inc. generate each year?
Baudax Bio, Inc. (:BXRX) has a recorded annual revenue of $1.27 M.
-
How much profit does Baudax Bio, Inc. generate each year?
Baudax Bio, Inc. (:BXRX) has a recorded net income of $1.27 M. Baudax Bio, Inc. has generated $-177.3 earnings per share over the last four quarters.
-
What is Baudax Bio, Inc.'s price-to-earnings ratio?
Baudax Bio, Inc. (:BXRX) has a price-to-earnings ratio of -0.16 and price/earnings-to-growth ratio is -0.
